In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
October 28th, 2005 | 28 | Yes |
Popular Name: Tamoxifen citrate Tamoxifen citrate
Find On: PubMed — Wikipedia — Google
CAS Numbers: 10540-29-1 , 106463-17-6 , 54965-24-1 , 54965-24-1, 10540-29-1 , 54965-24-1, 10540-29-1 [tamoxifen] , [10540-29-1] , [106463-17-6] , [54965-24-1]
10540-29-1; CPD001491671; SAM002703133; Tamoxifen
10540-29-1; D08559; Tamoplex (TN); Tamoxifen (INN); Tamoxifen (TN)
5-[(2R)-2-[[2-(2-Ethoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzenesulfonamide hydrochloride
54965-24-1; D00966; Nolvadex (TN); Tamoxifen citrate (JP16/USP)
54965-24-1; Prestwick_458; Tamoxifen citrate
CPD001491671; SAM002703133; Tamoxifen
DIPHENYLBUTENYLPHENOXYETHYLDIMETHYLAMINEHYDROXYPROPANETRICARBOXYLAT
Kessar; Nolvadex; Tamox; Tamoxan; Tamoxene; Tamoxin
tamoxifen drug standard solution
tamoxifen; tamoxifene; tamoxifeno; tamoxifenum
trans-2-[4-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethylamine
{2-[4-(1,2-Diphenyl-1-buten-1-yl)phenoxy]ethyl}dimethylamine 2-hydroxy-1,2,3-propanetricarboxylate (
{2-[4-(1,2-diphenylbut-1-en-1-yl)phenoxy]ethyl}dimethylamine
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 6.06 | 15.81 | -35.9 | 1 | 2 | 1 | 14 | 372.532 | 8 | ↓ |
Hi High (pH 8-9.5) | 6.06 | 13.36 | -4.97 | 0 | 2 | 0 | 12 | 371.524 | 8 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
ALOGPS_SOLUBILITY | 1.02e-03 g/l | DrugBank-approved |
Mp [°C] | 140 - 144 | Acros Organics |
Therapy | Anti-estrogen; relatively selective protein kinase C inhibitor | SMDC Iconix |
Indications | antineoplastic | KeyOrganics Bioactives |
Indications | breast cancer | KeyOrganics Bioactives |
UniProt Database Links | COM1_HUMAN; CUED2_HUMAN; CUZD1_RAT; ESR1_HUMAN; ESR2_HUMAN; F102A_HUMAN; FOXL2_BOVIN; FOXL2_CAPHI; FOXL2_ELLLU; FOXL2_HUMAN; FOXL2_MOUSE; FOXL2_PIG; FOXL2_RABIT; NLTP_HUMAN; NUMBL_MOUSE; NUMB_MOUSE | ChEBI |
Patent Database Links | EP0911321; EP0995748; EP1133996; EP1192945; EP1438962; EP1506775; EP1514877; EP1531181; EP1537858; EP1538164; EP1557085; EP1574499; EP1580188; EP1586323; EP1598081; EP1611879; EP1623712; EP1634607; EP1683523; EP1692936; EP1717247; EP1731142; EP1738752; EP | ChEBI |
Patent Database Links | EP1719527; EP1728863; EP1829534; EP1834637; EP1911449; US2005042279; US2007184076; US2007196272 | ChEBI |
therap | estrogen antagonist, antineoplastic | MicroSource Spectrum |
Target | Estrogen/progestogen Receptor | Selleck Chemicals |
H phrase | H302: Harmful if swallowed | Acros Organics |
H phrase | H302: Harmful if swallowed; H350: May cause cancer | Acros Organics |
Warnings | IRRITANT | Matrix Scientific |
PUBCHEM_SUBSTANCE_COMMENT | NCC_SAMPLE_SUPPLIER : LightBiologicals; NCC_SUPPLIER_STRUCTURE_ID : MZ-3027; NCC_SUPPLIER_SAMPLE_COMMENTS : WHITE POWDER | NIH Clinical Collection via PubChem |
P phrase | P201: Obtain special instructions before use | Acros Organics |
P phrase | P201: Obtain special instructions before use; P308 + P313: IF exposed or concerned: Get medical advice/attention; P301+ P312: IF SWALLOWED: Call a POISON CENTER or doctor/physician if you feel unwell | Acros Organics |
R phrase | R45: May cause cancer. | Acros Organics |
R phrase | R45: May cause cancer.; R22: Harmful if swallowed. | Acros Organics |
Reactome Database Links | REACT_13805; REACT_6956 | ChEBI |
S phrase | S53: Avoid exposure - obtain special instructions before use. | Acros Organics |
S phrase | S53: Avoid exposure - obtain special instructions before use.; S45: In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible). | Acros Organics |
PUBCHEM_SUBSTANCE_COMMENT | SAMPLE_SUPPLIER: LightBiologicals; SUPPLIER_STRUCTURE_ID: MZ-3027; SUPPLIER_COMMENTS: WHITE POWDER | NIH Clinical Collection via PubChem |
Hazard | T: Toxic | Acros Organics |
PUBCHEM_PATENT_ID | WO2000025767A2 | IBM Patent Data |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
EBP-1-E | 3-beta-hydroxysteroid-delta(8),delta(7)-isomerase (cluster #1 Of 1), Eukaryotic | Eukaryotes | 5 | 0.42 | Binding ≤ 10μM |
ESR1-1-E | Estrogen Receptor Alpha (cluster #1 Of 5), Eukaryotic | Eukaryotes | 8 | 0.40 | Binding ≤ 10μM |
ESR2-1-E | Estrogen Receptor Beta (cluster #1 Of 4), Eukaryotic | Eukaryotes | 3900 | 0.27 | Binding ≤ 10μM |
KCNH2-2-E | HERG (cluster #2 Of 5), Eukaryotic | Eukaryotes | 1585 | 0.29 | Binding ≤ 10μM |
MDR1-1-E | P-glycoprotein 1 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 100 | 0.35 | Binding ≤ 10μM |
O77823-1-E | Phosphodiesterase 4A (cluster #1 Of 1), Eukaryotic | Eukaryotes | 6800 | 0.26 | Binding ≤ 10μM |
PDE1A-1-E | Phosphodiesterase 1A (cluster #1 Of 1), Eukaryotic | Eukaryotes | 6800 | 0.26 | Binding ≤ 10μM |
PDE1B-1-E | Phosphodiesterase 1B (cluster #1 Of 1), Eukaryotic | Eukaryotes | 6750 | 0.26 | Binding ≤ 10μM |
PDE1C-1-E | Phosphodiesterase 1C (cluster #1 Of 1), Eukaryotic | Eukaryotes | 6800 | 0.26 | Binding ≤ 10μM |
Q8AWE3-1-E | Serine-threonine Protein Phosphatase 2A Regulatory Subunit (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3400 | 0.27 | Binding ≤ 10μM |
SGMR1-1-E | Sigma Opioid Receptor (cluster #1 Of 6), Eukaryotic | Eukaryotes | 35 | 0.37 | Binding ≤ 10μM |
ESR1-1-E | Estrogen Receptor Alpha (cluster #1 Of 3), Eukaryotic | Eukaryotes | 904 | 0.30 | Functional ≤ 10μM |
ESR2-1-E | Estrogen Receptor Beta (cluster #1 Of 2), Eukaryotic | Eukaryotes | 904 | 0.30 | Functional ≤ 10μM |
CP2B6-2-E | Cytochrome P450 2B6 (cluster #2 Of 4), Eukaryotic | Eukaryotes | 900 | 0.30 | ADME/T ≤ 10μM |
CP3A4-2-E | Cytochrome P450 3A4 (cluster #2 Of 4), Eukaryotic | Eukaryotes | 200 | 0.33 | ADME/T ≤ 10μM |
ERG2-2-F | C-8 Sterol Isomerase (cluster #2 Of 2), Fungal | Fungi | 1500 | 0.29 | Binding ≤ 10μM |
Z100267-1-O | Anti-estrogen Binding Site (AEBS) (cluster #1 Of 1), Other | Other | 12 | 0.40 | Binding ≤ 10μM |
Z50425-11-O | Plasmodium Falciparum (cluster #11 Of 22), Other | Other | 7943 | 0.26 | Functional ≤ 10μM |
Z80132-2-O | EL4 (Thymoma Cells) (cluster #2 Of 2), Other | Other | 535 | 0.31 | Functional ≤ 10μM |
Z80224-1-O | MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other | Other | 904 | 0.30 | Functional ≤ 10μM |
Z80227-1-O | MCF7-ADR (Breast Carcinoma Cells) (cluster #1 Of 2), Other | Other | 2000 | 0.28 | Functional ≤ 10μM |
Z80231-2-O | MCF7S (Breast Carcinoma Cells) (cluster #2 Of 2), Other | Other | 7200 | 0.26 | Functional ≤ 10μM |
Z80296-1-O | MVLN (cluster #1 Of 1), Other | Other | 300 | 0.33 | Functional ≤ 10μM |
Z80712-2-O | T47D (Breast Carcinoma Cells) (cluster #2 Of 7), Other | Other | 1000 | 0.30 | Functional ≤ 10μM |
Z81068-1-O | Ishikawa (Uterine Carcinoma Cells) (cluster #1 Of 1), Other | Other | 420 | 0.32 | Functional ≤ 10μM |
Z81245-1-O | MDA-MB-435 (Breast Carcinoma Cells) (cluster #1 Of 6), Other | Other | 50 | 0.37 | Functional ≤ 10μM |
Z81252-1-O | MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #1 Of 11), Other | Other | 9860 | 0.25 | Functional ≤ 10μM |
Z80936-1-O | HEK293 (Embryonic Kidney Fibroblasts) (cluster #1 Of 4), Other | Other | 10000 | 0.25 | ADME/T ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
EBP_HUMAN | Q15125 | 3-beta-hydroxysteroid-delta(8),delta(7)-isomerase, Human | 5 | 0.42 | Binding ≤ 1μM |
Z100267 | Z100267 | Anti-estrogen Binding Site (AEBS) | 1 | 0.45 | Binding ≤ 1μM |
ESR1_HUMAN | P03372 | Estrogen Receptor Alpha, Human | 100 | 0.35 | Binding ≤ 1μM |
ESR2_HUMAN | Q92731 | Estrogen Receptor Beta, Human | 11.9 | 0.40 | Binding ≤ 1μM |
MDR1_HUMAN | P08183 | P-glycoprotein 1, Human | 100 | 0.35 | Binding ≤ 1μM |
SGMR1_HUMAN | Q99720 | Sigma Opioid Receptor, Human | 35 | 0.37 | Binding ≤ 1μM |
EBP_HUMAN | Q15125 | 3-beta-hydroxysteroid-delta(8),delta(7)-isomerase, Human | 5 | 0.42 | Binding ≤ 10μM |
Z100267 | Z100267 | Anti-estrogen Binding Site (AEBS) | 1 | 0.45 | Binding ≤ 10μM |
ERG2_YEAST | P32352 | C-8 Sterol Isomerase, Yeast | 1500 | 0.29 | Binding ≤ 10μM |
ESR1_HUMAN | P03372 | Estrogen Receptor Alpha, Human | 100 | 0.35 | Binding ≤ 10μM |
ESR2_HUMAN | Q92731 | Estrogen Receptor Beta, Human | 11.9 | 0.40 | Binding ≤ 10μM |
KCNH2_HUMAN | Q12809 | HERG, Human | 1584.89319 | 0.29 | Binding ≤ 10μM |
MDR1_HUMAN | P08183 | P-glycoprotein 1, Human | 100 | 0.35 | Binding ≤ 10μM |
PDE1A_HUMAN | P54750 | Phosphodiesterase 1A, Human | 6750 | 0.26 | Binding ≤ 10μM |
PDE1B_RAT | Q01066 | Phosphodiesterase 1B, Rat | 6750 | 0.26 | Binding ≤ 10μM |
PDE1B_HUMAN | Q01064 | Phosphodiesterase 1B, Human | 6750 | 0.26 | Binding ≤ 10μM |
PDE1C_HUMAN | Q14123 | Phosphodiesterase 1C, Human | 6750 | 0.26 | Binding ≤ 10μM |
O77823_PIG | O77823 | Phosphodiesterase 4A, Pig | 6800 | 0.26 | Binding ≤ 10μM |
Q8AWE3_CHICK | Q8AWE3 | Serine-threonine Protein Phosphatase 2A Regulatory Subunit, Chick | 3400 | 0.27 | Binding ≤ 10μM |
SGMR1_HUMAN | Q99720 | Sigma Opioid Receptor, Human | 35 | 0.37 | Binding ≤ 10μM |
Z80132 | Z80132 | EL4 (Thymoma Cells) | 535 | 0.31 | Functional ≤ 10μM |
ESR1_HUMAN | P03372 | Estrogen Receptor Alpha, Human | 2540 | 0.28 | Functional ≤ 10μM |
ESR2_HUMAN | Q92731 | Estrogen Receptor Beta, Human | 1660 | 0.29 | Functional ≤ 10μM |
Z81068 | Z81068 | Ishikawa (Uterine Carcinoma Cells) | 170 | 0.34 | Functional ≤ 10μM |
Z80224 | Z80224 | MCF7 (Breast Carcinoma Cells) | 0.11 | 0.50 | Functional ≤ 10μM |
Z80227 | Z80227 | MCF7-ADR (Breast Carcinoma Cells) | 2000 | 0.28 | Functional ≤ 10μM |
Z80231 | Z80231 | MCF7S (Breast Carcinoma Cells) | 7200 | 0.26 | Functional ≤ 10μM |
Z81252 | Z81252 | MDA-MB-231 (Breast Adenocarcinoma Cells) | 10000 | 0.25 | Functional ≤ 10μM |
Z81245 | Z81245 | MDA-MB-435 (Breast Carcinoma Cells) | 50 | 0.37 | Functional ≤ 10μM |
Z80296 | Z80296 | MVLN | 300 | 0.33 | Functional ≤ 10μM |
Z50425 | Z50425 | Plasmodium Falciparum | 7943.28235 | 0.25 | Functional ≤ 10μM |
Z80712 | Z80712 | T47D (Breast Carcinoma Cells) | 1000 | 0.30 | Functional ≤ 10μM |
CP2B6_HUMAN | P20813 | Cytochrome P450 2B6, Human | 900 | 0.30 | ADME/T ≤ 10μM |
CP3A4_HUMAN | P08684 | Cytochrome P450 3A4, Human | 200 | 0.33 | ADME/T ≤ 10μM |
Z80936 | Z80936 | HEK293 (Embryonic Kidney Fibroblasts) | 10000 | 0.25 | ADME/T ≤ 10μM |
Description | Species |
---|---|
FMO oxidizes nucleophiles | |
Glucuronidation |
Description | Species |
---|---|
Abacavir transmembrane transport | |
ABC-family proteins mediated transport | |
Aflatoxin activation and detoxification | |
Cam-PDE 1 activation | |
cGMP effects | |
Cholesterol biosynthesis | |
CYP2E1 reactions | |
DARPP-32 events | |
Fatty acids | |
G alpha (s) signalling events | |
Nuclear Receptor transcription pathway | |
Nuclear signaling by ERBB4 | |
Voltage gated Potassium channels | |
Xenobiotics |